Innovotech Inc Net Assets

Latest as of June 2026: CA$2.59 Million CAD ≈ $1.87 Million USD

Innovotech Inc net assets. Based on the latest financial reports, Innovotech Inc (IOT) has net assets worth CA$2.59 Million CAD (≈ $1.87 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$3.59 Million ≈ $2.59 Million USD) and total liabilities (CA$993.81K ≈ $718.91K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore IOT net assets growth trend to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets CA$2.59 Million
% of Total Assets 72.28%
Annual Growth Rate 6.81%
5-Year Change 209.98%
10-Year Change N/A
Growth Volatility 184.04

Net Assets of Innovotech Inc (2003–2025)

Net assets of Innovotech Inc from 2003 to 2025. This chart illustrates how Innovotech Inc's net assets have evolved over time, based on quarterly financial data. See Innovotech Inc net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Innovotech Inc (2003–2025)

The table below shows the annual net assets of Innovotech Inc from 2003 to 2025. For live market cap and overall valuation, see Innovotech Inc market cap and net worth.

Year Net Assets Change
2025-12-31 CA$3.65 Million
≈ $2.64 Million		 +39.08%
2024-12-31 CA$2.62 Million
≈ $1.90 Million		 +162.68%
2023-12-31 CA$998.60K
≈ $722.37K		 -5.57%
2022-12-31 CA$1.06 Million
≈ $764.99K		 -10.15%
2021-12-31 CA$1.18 Million
≈ $851.37K		 +82.48%
2020-12-31 CA$644.98K
≈ $466.57K		 +557.56%
2019-12-31 CA$98.09K
≈ $70.95K		 +4.94%
2018-12-31 CA$93.47K
≈ $67.61K		 -48.50%
2017-12-31 CA$181.51K
≈ $131.30K		 +114.90%
2016-12-31 CA$-1.22 Million
≈ $-881.43K		 -21.49%
2015-12-31 CA$-1.00 Million
≈ $-725.51K		 -30.99%
2014-12-31 CA$-765.66K
≈ $-553.87K		 -34.48%
2013-12-31 CA$-569.33K
≈ $-411.85K		 -168.03%
2003-12-31 CA$836.94K
≈ $605.43K		 -0.53%
2003-09-30 CA$841.40K
≈ $608.65K		 --

Equity Component Analysis

This analysis shows how different components contribute to Innovotech Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 821798800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Innovotech Inc Net Assets Breakdown (December 2025)

Innovotech Inc net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Other Components CA$11.83 Million 328.82%
Total Equity CA$3.60 Million 100.00%

Innovotech Inc Competitors by Market Cap

The table below lists competitors of Innovotech Inc ranked by their market capitalization.

Company Market Cap
Kanger International Bhd
KLSE:0170
 $2.56 Million
Playfair Mining Ltd.
V:PLY
 $2.56 Million
Galilee Energy Ltd
AU:GLL
 $2.56 Million
Galore Resources Inc
V:GRI
 $2.57 Million
Bluechiip Ltd
AU:BCT
 $2.56 Million
Golden Goliath Resources Ltd.
V:GNG
 $2.56 Million
BCM Alliance Bhd
KLSE:0187
 $2.55 Million
ZHENRO PROP.GRP DL-00001
F:1ZZ
 $2.55 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Innovotech Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,565,111 to 3,596,981, a change of 1,031,870 (40.2%).
  • Net income of 94,375 contributed positively to equity growth.
  • Other factors increased equity by 937,495.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CA$94.38K +2.62%
Other Changes CA$937.50K +26.06%
Total Change CA$- 40.23%

Book Value vs Market Value Analysis

This analysis compares Innovotech Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.98x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 12.08x to 0.98x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 CA$0.01 CA$0.07 x
2018-12-31 CA$0.00 CA$0.07 x
2019-12-31 CA$0.00 CA$0.07 x
2020-12-31 CA$0.02 CA$0.07 x
2021-12-31 CA$0.03 CA$0.07 x
2022-12-31 CA$0.03 CA$0.07 x
2023-12-31 CA$0.02 CA$0.07 x
2024-12-31 CA$0.05 CA$0.07 x
2025-12-31 CA$0.07 CA$0.07 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Innovotech Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 2.62%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.08%
  • • Asset Turnover: 1.02x
  • • Equity Multiplier: 1.23x
  • Recent ROE (2.62%) is below the historical average (16.98%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2003 -1.62% 0.00% 0.00x 1.05x CA$-97.77K
2003 -1.74% 0.00% 0.00x 1.00x CA$-98.22K
2013 0.00% -93.07% 2.10x 0.00x CA$-770.32K
2014 0.00% -23.23% 2.21x 0.00x CA$-133.07K
2015 0.00% -35.41% 3.32x 0.00x CA$-150.31K
2016 0.00% -21.43% 3.09x 0.00x CA$-93.69K
2017 415.07% 76.07% 1.88x 2.90x CA$735.23K
2018 -136.55% -15.43% 3.04x 2.91x CA$-136.98K
2019 -49.71% -4.94% 3.59x 2.80x CA$-58.57K
2020 16.48% 8.91% 1.45x 1.28x CA$41.82K
2021 31.19% 24.78% 1.03x 1.22x CA$249.44K
2022 -12.91% -12.13% 0.92x 1.16x CA$-242.26K
2023 -16.93% -13.32% 0.97x 1.31x CA$-250.64K
2024 8.76% 10.24% 0.68x 1.26x CA$-31.78K
2025 2.62% 2.08% 1.02x 1.23x CA$-265.32K

Industry Comparison

This section compares Innovotech Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $24,667,505
  • Average return on equity (ROE) among peers: -150.75%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Innovotech Inc (IOT) CA$2.59 Million -1.62% 0.38x $2.56 Million
Appili Therapeutics Inc (APLI) $4.87 Million -81.69% 0.48x $464.29K
Aptose Biosciences Inc (APS) $-2.90 Million 0.00% 0.00x $4.43 Million
Arch Biopartners Inc (ARCH) $-5.51 Million 0.00% 0.00x $40.79 Million
Biomind Labs Inc (BMND) $-1.74 Million 0.00% 0.00x $19.92 Million
Cybin Inc (CYBN) $237.20 Million -47.70% 0.09x $301.37 Million
Eastwood Bio-Medical Canada Inc (EBM) $-294.20K 0.00% 0.00x $89.55 Million
Eupraxia Pharmaceuticals Inc (EPRX) $5.11 Million -84.55% 0.14x $348.80 Million
Devonian Health Group Inc (GSD) $12.74 Million -25.03% 0.50x $15.09 Million
Helix BioPharma Corp. (HBP) $-3.28 Million 0.00% 0.00x $54.70 Million
Hemostemix Inc (HEM) $487.80K -1268.49% 2.41x $8.18 Million

About Innovotech Inc

V:IOT Canada Biotechnology
Market Cap
$2.56 Million
CA$3.54 Million CAD
Market Cap Rank
#29735 Global
#1413 in Canada
Share Price
CA$0.07
Change (1 day)
-7.14%
52-Week Range
CA$0.07 - CA$0.29
All Time High
CA$0.34
Categories
Companies in Canada Biotechnology
About

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more